Dr. Nathan Benaich is the Founder and General Partner of Air Street Capital, a venture capital firm investing in early-stage AI-first technology and life science companies. He also serves as Trustee at RAAIS Foundation. He served as Board Member at Ravelin. He serves as Scientist in Residence at Point Nine Capital. His investments include Allcyte (acq. Exscientia), Intenseye, Tractable, Graphcore, V7, Mapillary (acq. Facebook), and Thought Machine. He is the co-author of the annual State of AI Report and the newsletter, your guide to AI. He also leads Spinout.fyi, which seeks to improve university spinout creation starting with open data on deal terms, and The RAAIS Foundation, a non-profit that runs the annual RAAIS summit and funds open-source AI fellowships. He holds a Ph.D. in cancer biology from the University of Cambridge and a BA from Williams College.